Kinarus Therapeutics Holding AG
SIX:KNRS

Watchlist Manager
Kinarus Therapeutics Holding AG Logo
Kinarus Therapeutics Holding AG
SIX:KNRS
Watchlist
Price: 15 CHF 416 566.67% Market Closed
Market Cap: 19.5B CHF
Have any thoughts about
Kinarus Therapeutics Holding AG?
Write Note
Section:
 

Relative Value

KNRS doesn't have a meaningful market cap.

There is not enough data to reliably calculate the relative value of KNRS.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

KNRS Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Valuation Multiples

N/A
P/S
P/S
Price to Sales
N/A
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
0.5
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-1 428.6
Median 5Y
-44 574.6
Industry
9.2
More Details
Negative
P/OCF
P/OCF
Price to OCF
N/A
vs History
vs Industry
Median 3Y
-54 390.3
Median 5Y
-132 793.1
Industry
3.5
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
Median 3Y
-452 946.5
Median 5Y
-19 526 655.3
Industry
10.5
More Details
Negative
P/B
P/B
Price to Book Value
N/A
vs History
vs Industry
59
Median 3Y
-116 472
Median 5Y
-119 795.4
Industry
2.1
More Details
N/A
EV/S
EV/S
Enterprise Value to Sales
N/A
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
0.9
More Details
N/A
EV/GP
EV/GP
Enterprise Value to Gross Profit
N/A
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
3
More Details
Negative
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
N/A
vs History
vs Industry
65
Median 3Y
-46 739.6
Median 5Y
-87 646.8
Industry
6.6
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
48
Median 3Y
-21 155.9
Median 5Y
-69 918.9
Industry
10.2
More Details
Negative
EV/OCF
EV/OCF
Enterprise Value to OCF
N/A
vs History
vs Industry
76
Median 3Y
-54 393.6
Median 5Y
-132 793.3
Industry
6.4
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
57
Median 3Y
-54 393.6
Median 5Y
-132 793.3
Industry
10
More Details
355 030.1
EV/IC
EV/IC
Enterprise Value to IC
355 030.1
vs History
14
vs Industry
100
Median 3Y
4 552.3
Median 5Y
4 552.3
Industry
0.8
More Details

Multiples Across Competitors

KNRS Competitors Multiples
Kinarus Therapeutics Holding AG Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CH
Kinarus Therapeutics Holding AG
SIX:KNRS
19.5B CHF 0 -1 404.3 -1 404.9 -1 404.9
US
Delta Air Lines Inc
NYSE:DAL
40.4B USD 0.7 8.7 5.5 9.1
US
United Airlines Holdings Inc
NASDAQ:UAL
33.3B USD 0.6 12 8.8 8.8
IE
Ryanair Holdings PLC
LSE:RYA
15.4B EUR 1.1 8 4.5 6.8
IN
Interglobe Aviation Ltd
NSE:INDIGO
1.8T INR 2.4 26.9 11.3 20.7
US
Southwest Airlines Co
NYSE:LUV
20.6B USD 0.8 -420 12.5 -45.1
UK
International Consolidated Airlines Group SA
LSE:IAG
14.8B GBP 0.5 6.8 57.5 92
CN
Air China Ltd
SSE:601111
134.4B CNY 0.8 -282.3 -430.8 -430.8
CN
China Southern Airlines Co Ltd
SSE:600029
120B CNY 0.7 -33.7 63.3 63.3
SG
Singapore Airlines Ltd
SGX:C6L
19B SGD 1 9.6 4.9 10.5
US
American Airlines Group Inc
NASDAQ:AAL
11.4B USD 0.2 41.5 10.3 10.3
P/E Multiple
Earnings Growth P/E to Growth
CH
Kinarus Therapeutics Holding AG
SIX:KNRS
Average P/E: 16.2
Negative Multiple: -1 404.3 		N/A N/A
US
Delta Air Lines Inc
NYSE:DAL
8.7
14%
0.6
US
United Airlines Holdings Inc
NASDAQ:UAL
12
82%
0.1
IE
R
Ryanair Holdings PLC
LSE:RYA
8
48%
0.2
IN
Interglobe Aviation Ltd
NSE:INDIGO
26.9
18%
1.5
US
Southwest Airlines Co
NYSE:LUV
Negative Multiple: -420
209%
N/A
UK
International Consolidated Airlines Group SA
LSE:IAG
6.8
7%
1
CN
Air China Ltd
SSE:601111
Negative Multiple: -282.3 N/A N/A
CN
China Southern Airlines Co Ltd
SSE:600029
Negative Multiple: -33.7 N/A N/A
SG
Singapore Airlines Ltd
SGX:C6L
9.6
-50%
N/A
US
American Airlines Group Inc
NASDAQ:AAL
41.5
132%
0.3
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CH
Kinarus Therapeutics Holding AG
SIX:KNRS
Average EV/EBIT: 27.7
Negative Multiple: -1 404.9 		N/A N/A
US
Delta Air Lines Inc
NYSE:DAL
9.1
20%
0.5
US
United Airlines Holdings Inc
NASDAQ:UAL
8.8
27%
0.3
IE
R
Ryanair Holdings PLC
LSE:RYA
6.8
37%
0.2
IN
Interglobe Aviation Ltd
NSE:INDIGO
20.7
33%
0.6
US
Southwest Airlines Co
NYSE:LUV
Negative Multiple: -45.1
360%
N/A
UK
International Consolidated Airlines Group SA
LSE:IAG
92
25%
3.6
CN
Air China Ltd
SSE:601111
Negative Multiple: -430.8
7 484%
N/A
CN
China Southern Airlines Co Ltd
SSE:600029
63.3
180%
0.4
SG
Singapore Airlines Ltd
SGX:C6L
10.5
-46%
N/A
US
American Airlines Group Inc
NASDAQ:AAL
10.3
-9%
N/A

See Also

Summary
KNRS intrinsic value, competitors valuation, and company profile.
DCF Valuation
KNRS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
KNRS stock valuation using valuation multiples.
Wall Street Estimates
KNRS price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
KNRS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 210,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.